NCT06887205Recruiting
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
Source: ClinicalTrials.gov · Last updated 18 Jun 2026
Brief summary (registry, in English)
To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 14 Mar 2025
- Start date
- 10 Jun 2026
- Primary completion date
- 1 Sept 2028
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Melanoma
- NCT number
- NCT06887205
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 10 Jun 2026 to the primary completion date, 1 Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participant staking anticoagulants within 7 days prior to surgery.
- Participants that are known to be pregnant at the time of surgery.
Other
- Participants with BMI greater than 50.0
Who the study is looking for
- Participants greater than or equal to 18 years of age.
- Participants willing to participate.
- Participants able to complete informed consent.
- Participants with a diagnosis of Melanoma undergoing ALND or ILND.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.